Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #31
    You may have noticed a recent item in In Sequence in which Illumina indicate a total of 1,500 installed machines (theirs plus others). See:

    The google map is nice but still very incomplete - I guess many owners are not motivated or not aware of SequAnswers (too bad for them!)...
    By the way, if you're an academic (a pretty loose definition) you can get free access to In Sequence and to the other GenomeWeb newsletters (BioArray news, Pharmacogenomics..). This may require an email to the person in charge of the site, but it works!

    Cheers,

    Bertrand
    Bertrand Jordan
    Marseille-Nice Genopole
    Luminy Science Park
    13288 Marseille, FRANCE

    Comment


    • #32
      I think the difference between the ~1500 reported by Illumina and the 540 (as of 20100405) in the HTS website comes mainly from people not being aware of the site, rather than from being reluctant to disclose the machines they have.

      Over the weekend, I did a very simple Google search for queries like:
      "DNA sequencing facility" Illumina OR 454 OR SOLID site:.edu

      and managed to find an extra half a dozen centers that have a website specifying the machines they have, prices, etc. but they weren't in the map.

      There might be a portion of the machines that are in pharma companies and don't want to advertise the level of sequencing they are doing, but that is, I would say, in the few hundreds. I think the map could easily reach ~1250 out of the ~1500 if all the machines in all public centers were in the database.

      Originally posted by brjordan View Post
      You may have noticed a recent item in In Sequence in which Illumina indicate a total of 1,500 installed machines (theirs plus others). See:

      The google map is nice but still very incomplete - I guess many owners are not motivated or not aware of SequAnswers (too bad for them!)...
      By the way, if you're an academic (a pretty loose definition) you can get free access to In Sequence and to the other GenomeWeb newsletters (BioArray news, Pharmacogenomics..). This may require an email to the person in charge of the site, but it works!

      Cheers,

      Bertrand

      Comment


      • #33
        If there are 1500 Illuminas out there then that means the map is about 1/3 complete. Which is pretty good for a community-run resource like this but I agree we could do better. If you do find a centre not in there, please put a placeholder down!

        The results, so far, of the serial number challenge will be announced real soon now, and they are quite interesting!

        Comment


        • #34
          Another piece of "numerical" news: Roche announces 139 M CHF (~139 M USD) sequencing sales in 2009, based exclusively on the 454 system. If I assume that 50% of this is new machine sales, and a unit price of 500 K USD, this works out to 140 454 systems sold last year, a figure that looks fairly reasonable. Of course this puts Roche last of the "big three", and you can understand why they launch the "GS junior"...
          Bertrand Jordan
          Marseille-Nice Genopole
          Luminy Science Park
          13288 Marseille, FRANCE

          Comment


          • #35
            Hi there,
            anything new from the tanks? I only see 27 submissions on your web site

            Comment


            • #36
              So how many machines have been shipped to its customers, may the 27 submissions is not enough to predict the shipped machines?

              Comment

              Latest Articles

              Collapse

              • seqadmin
                Current Approaches to Protein Sequencing
                by seqadmin


                Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
                04-04-2024, 04:25 PM
              • seqadmin
                Strategies for Sequencing Challenging Samples
                by seqadmin


                Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
                03-22-2024, 06:39 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by seqadmin, 04-11-2024, 12:08 PM
              0 responses
              24 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 04-10-2024, 10:19 PM
              0 responses
              25 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 04-10-2024, 09:21 AM
              0 responses
              22 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 04-04-2024, 09:00 AM
              0 responses
              52 views
              0 likes
              Last Post seqadmin  
              Working...
              X